Trilostane
Back to searchMolecule Structure
Scientific Name
Trilostane
Description of the Drug
Not Available
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01108
http://www.drugbank.ca/drugs/DB01108
Brand Name(s)
Modrastane, Modrenal
Company Owner(s)
Bioenvision Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| 3-beta-hydroxysteroid dehydrogenase/delta 5–>4-isomerase type II | SINGLE PROTEIN | INHIBITOR | CHEMBL3670 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL7517 | |
| PharmGKB | PA164748507 | |
| Human Metabolome Database | HMDB0015240 | |
| DrugBank | DB01108 | |
| PubChem: Thomson Pharma | 14753126 | 14850960 |
| PubChem | 656583 | |
| Mcule | MCULE-8531625687 | |
| Nikkaji | J108.016D | |
| BindingDB | 50247882 | |
| EPA CompTox Dashboard | DTXSID9023706 | |
| DrugCentral | 2746 | |
| Brenda | 1479 | |
| ChemicalBook | CB4768762 | |
| Guide to Pharmacology | 6850 | |
| rxnorm | TRILOSTANE | |
| KEGG Ligand | C12580 | |
| ChEBI | 32260 | |
| ZINC | ZINC000100038546 |
